Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	PLC activating G protein-coupled glutamate receptor activity	GRM1 GRM5	2.90e-05	2	108	2	GO:0001639
GeneOntologyMolecularFunction	transforming growth factor beta receptor activity	TGFBR3 BMPR1A BMPR1B	4.23e-05	13	108	3	GO:0005024
GeneOntologyMolecularFunction	protein binding involved in heterotypic cell-cell adhesion	NRCAM JUP IZUMO1	1.18e-04	18	108	3	GO:0086080
GeneOntologyMolecularFunction	transmembrane receptor protein serine/threonine kinase activity	TGFBR3 BMPR1A BMPR1B	1.64e-04	20	108	3	GO:0004675
GeneOntologyMolecularFunction	neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration	GRM1 GRM5	1.73e-04	4	108	2	GO:0099583
GeneOntologyMolecularFunction	BMP binding	TGFBR3 BMPR1A BMPR1B	2.20e-04	22	108	3	GO:0036122
GeneOntologyMolecularFunction	alpha-1,4-glucosidase activity	SI MGAM2	2.87e-04	5	108	2	GO:0004558
GeneOntologyMolecularFunction	G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential	GRM1 GRM5	2.87e-04	5	108	2	GO:0099530
GeneOntologyMolecularFunction	transforming growth factor beta receptor activity, type I	BMPR1A BMPR1B	2.87e-04	5	108	2	GO:0005025
GeneOntologyMolecularFunction	cell-cell adhesion mediator activity	CLSTN3 NRCAM JUP IZUMO1	3.33e-04	61	108	4	GO:0098632
GeneOntologyMolecularFunction	alkaline phosphatase activity	ALPI ALPG	4.29e-04	6	108	2	GO:0004035
GeneOntologyMolecularFunction	antigen binding	IGLV2-23 IGHV8-51-1 IGKV2D-28 KLRD1 IGHV4-4 IGKV2-30	5.88e-04	190	108	6	GO:0003823
GeneOntologyMolecularFunction	alpha-glucosidase activity	SI MGAM2	5.98e-04	7	108	2	GO:0090599
GeneOntologyMolecularFunction	cell adhesion mediator activity	CLSTN3 NRCAM JUP IZUMO1	7.70e-04	76	108	4	GO:0098631
GeneOntologyMolecularFunction	BMP receptor activity	BMPR1A BMPR1B	7.94e-04	8	108	2	GO:0098821
GeneOntologyMolecularFunction	G protein-coupled glutamate receptor activity	GRM1 GRM5	1.02e-03	9	108	2	GO:0098988
GeneOntologyMolecularFunction	adenylate cyclase inhibiting G protein-coupled glutamate receptor activity	GRM1 GRM5	1.02e-03	9	108	2	GO:0001640
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	TGFBR3 BMPR1A BMPR1B TIE1	1.17e-03	85	108	4	GO:0019199
GeneOntologyBiologicalProcess	production of molecular mediator of immune response	IGLV3-32 EPG5 MALT1 IGLV2-23 FCRL3 IGKV2D-30 IGKV2D-28 PLCG2 CLNK IGKV2-30 IGKV2-28	1.60e-05	403	115	11	GO:0002440
GeneOntologyCellularComponent	immunoglobulin complex	IGLV3-32 IGLV2-23 IGHV8-51-1 IGKV2D-30 IGKV2D-28 IGHV4-4 IGKV2-30 IGKV2-28	4.10e-06	166	116	8	GO:0019814
GeneOntologyCellularComponent	receptor complex	GABRD CRLF1 TSHR GRM1 TGFBR3 BMPR1A BMPR1B TIE1 TRBV7-7 FSHR TRBV5-8 KLRD1 TRAV26-2	2.08e-05	581	116	13	GO:0043235
GeneOntologyCellularComponent	protein kinase CK2 complex	CSNK2A1 CSNK2A3	1.82e-04	4	116	2	GO:0005956
GeneOntologyCellularComponent	protein complex involved in cell-cell adhesion	IZUMO1 GLIPR1L1	4.51e-04	6	116	2	GO:0098635
GeneOntologyCellularComponent	HFE-transferrin receptor complex	BMPR1A BMPR1B	8.36e-04	8	116	2	GO:1990712
Domain	GluR_Homer-bdg	GRM1 GRM5	3.07e-05	2	104	2	PF10606
Domain	Metabotropic_Glu_rcpt_Homer-bd	GRM1 GRM5	3.07e-05	2	104	2	IPR019588
Domain	GPCR_3_mtglu_rcpt_1	GRM1 GRM5	3.07e-05	2	104	2	IPR001256
Domain	GluR_Homer-bdg	GRM1 GRM5	3.07e-05	2	104	2	SM01229
Domain	GPCR_3_mtglu_rcpt_5	GRM1 GRM5	3.07e-05	2	104	2	IPR000202
Domain	Alk_phosphatase	ALPI ALPG	1.83e-04	4	104	2	PF00245
Domain	Alkaline_phosphatase_AS	ALPI ALPG	1.83e-04	4	104	2	IPR018299
Domain	Gal_mutarotase_N	SI MGAM2	1.83e-04	4	104	2	IPR031727
Domain	Alkaline_phosphatase	ALPI ALPG	1.83e-04	4	104	2	IPR001952
Domain	NtCtMGAM_N	SI MGAM2	1.83e-04	4	104	2	PF16863
Domain	alkPPc	ALPI ALPG	1.83e-04	4	104	2	SM00098
Domain	ALKALINE_PHOSPHATASE	ALPI ALPG	1.83e-04	4	104	2	PS00123
Domain	Glyco_hydro_31_AS	SI MGAM2	4.54e-04	6	104	2	IPR030458
Domain	Gphrmn_rcpt_fam	TSHR FSHR	4.54e-04	6	104	2	IPR002131
Domain	Glyco_hydro_31	SI MGAM2	6.33e-04	7	104	2	IPR000322
Domain	GS_dom	BMPR1A BMPR1B	6.33e-04	7	104	2	IPR003605
Domain	GS	BMPR1A BMPR1B	6.33e-04	7	104	2	PS51256
Domain	Glyco_hydro_31	SI MGAM2	6.33e-04	7	104	2	PF01055
Domain	TGF_beta_GS	BMPR1A BMPR1B	6.33e-04	7	104	2	PF08515
Domain	GS	BMPR1A BMPR1B	6.33e-04	7	104	2	SM00467
Domain	GLYCOSYL_HYDROL_F31_1	SI MGAM2	6.33e-04	7	104	2	PS00129
Domain	ig	NRCAM MALT1 FCRL3 TIE1 ADGRF5 SIGLEC1	6.81e-04	190	104	6	PF00047
Domain	Immunoglobulin	NRCAM MALT1 FCRL3 TIE1 ADGRF5 SIGLEC1	6.81e-04	190	104	6	IPR013151
Domain	GPCR_3_mtglu_rcpt	GRM1 GRM5	8.41e-04	8	104	2	IPR000162
Domain	Trefoil	SI MGAM2	8.41e-04	8	104	2	PF00088
Domain	P_TREFOIL_2	SI MGAM2	1.08e-03	9	104	2	PS51448
Domain	PD	SI MGAM2	1.08e-03	9	104	2	SM00018
Domain	ANF_lig-bd_rcpt	GRM1 GRM5 GUCY2F	1.14e-03	37	104	3	IPR001828
Domain	ANF_receptor	GRM1 GRM5 GUCY2F	1.14e-03	37	104	3	PF01094
Domain	Peripla_BP_I	GRM1 GRM5 GUCY2F	1.33e-03	39	104	3	IPR028082
Domain	LRR_5	TSHR FSHR	1.34e-03	10	104	2	PF13306
Domain	LRR_5	TSHR FSHR	1.34e-03	10	104	2	IPR026906
Domain	Allrgn_V5/Tpx1_CS	CRISP2 GLIPR1L1	1.34e-03	10	104	2	IPR018244
Domain	Activin_recp	BMPR1A BMPR1B	1.34e-03	10	104	2	PF01064
Domain	Activin_recp	BMPR1A BMPR1B	1.34e-03	10	104	2	IPR000472
Domain	-	SI MGAM2	1.63e-03	11	104	2	4.10.110.10
Domain	CRISP_1	CRISP2 GLIPR1L1	1.63e-03	11	104	2	PS01009
Domain	CRISP_2	CRISP2 GLIPR1L1	1.63e-03	11	104	2	PS01010
Domain	TGFB_receptor	BMPR1A BMPR1B	1.95e-03	12	104	2	IPR000333
Domain	P_trefoil_dom	SI MGAM2	1.95e-03	12	104	2	IPR000519
Domain	NCD3G	GRM1 GRM5	2.30e-03	13	104	2	PF07562
Domain	GPCR_3_9-Cys_dom	GRM1 GRM5	2.30e-03	13	104	2	IPR011500
Domain	-	CASP10 MALT1	2.68e-03	14	104	2	3.40.50.1460
Domain	Pept_C14_p20	CASP10 MALT1	2.68e-03	14	104	2	IPR001309
Domain	Caspase-like_dom	CASP10 MALT1	2.68e-03	14	104	2	IPR029030
Domain	CASPASE_P20	CASP10 MALT1	2.68e-03	14	104	2	PS50208
Domain	GPCR_3_CS	GRM1 GRM5	2.68e-03	14	104	2	IPR017979
Domain	CAP	CRISP2 GLIPR1L1	3.08e-03	15	104	2	PF00188
Domain	SCP	CRISP2 GLIPR1L1	3.08e-03	15	104	2	SM00198
Domain	Allrgn_V5/Tpx1	CRISP2 GLIPR1L1	3.08e-03	15	104	2	IPR001283
Domain	-	CRISP2 GLIPR1L1	3.08e-03	15	104	2	3.40.33.10
Domain	CAP_domain	CRISP2 GLIPR1L1	3.08e-03	15	104	2	IPR014044
Domain	Glycoside_hydrolase_SF	SI HPSE MGAM2	3.21e-03	53	104	3	IPR017853
Domain	CADHERIN_1	CLSTN3 PCDHGB3 PCDHA10 CDH18	3.67e-03	113	104	4	PS00232
Domain	Cadherin	CLSTN3 PCDHGB3 PCDHA10 CDH18	3.67e-03	113	104	4	PF00028
Domain	FN3	PAPPA2 CRLF1 NRCAM TRIM42 TIE1	3.77e-03	185	104	5	SM00060
Domain	CADHERIN_2	CLSTN3 PCDHGB3 PCDHA10 CDH18	3.79e-03	114	104	4	PS50268
Domain	-	CLSTN3 PCDHGB3 PCDHA10 CDH18	3.79e-03	114	104	4	2.60.40.60
Domain	-	PAPPA2 CRLF1 NRCAM TRIM42 MALT1 FCRL3 TIE1 IZUMO1 ADGRF5 SIGLEC1	3.87e-03	663	104	10	2.60.40.10
Domain	CA	CLSTN3 PCDHGB3 PCDHA10 CDH18	3.91e-03	115	104	4	SM00112
Domain	Gal_mutarotase_SF_dom	SI MGAM2	3.95e-03	17	104	2	IPR011013
Domain	Cadherin-like	CLSTN3 PCDHGB3 PCDHA10 CDH18	4.03e-03	116	104	4	IPR015919
Domain	Cadherin	CLSTN3 PCDHGB3 PCDHA10 CDH18	4.28e-03	118	104	4	IPR002126
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGLV2-23 IGKV2D-30 IGKV2D-28 PLCG2 IGKV2-30 IGKV2-28 PLD4	6.45e-07	82	86	7	M27110
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	IGLV2-23 IGKV2D-30 IGKV2D-28 PLCG2 IGKV2-30 IGKV2-28	1.38e-05	86	86	6	M601
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGLV2-23 IGKV2D-30 IGKV2D-28 PLCG2 IGKV2-30 IGKV2-28	1.38e-05	86	86	6	M27206
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGLV2-23 IGKV2D-30 IGKV2D-28 PLCG2 IGKV2-30 IGKV2-28	1.47e-05	87	86	6	M27205
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGKV2D-28 PLCG2 IGHV4-4 IGKV2-28 PLD4	2.25e-05	56	86	5	MM14815
Pathway	REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS	IGLV2-23 IGKV2D-30 IGKV2D-28 PLCG2 IGKV2-30 IGKV2-28	2.43e-05	95	86	6	M29842
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	IGLV2-23 IGKV2D-30 IGKV2D-28 PLCG2 IGKV2-30 IGKV2-28 PLD4	2.63e-05	143	86	7	M27107
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 IGKV2-28	3.42e-05	61	86	5	M27581
Pathway	REACTOME_FCGR_ACTIVATION	IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 IGKV2-28	6.21e-05	69	86	5	M27108
Pathway	REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA	IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 IGKV2-28	6.21e-05	69	86	5	M27150
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	MALT1 IGLV2-23 IGKV2D-30 IGKV2D-28 PLCG2 IGKV2-30 IGKV2-28	6.81e-05	166	86	7	M608
Pathway	REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 IGKV2-28	7.13e-05	71	86	5	M1078
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 IGKV2-28	7.13e-05	71	86	5	M27203
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 IGKV2-28	1.26e-04	80	86	5	M6121
Pathway	REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING	MALT1 IGLV2-23 IGKV2D-30 IGKV2D-28 PLCG2 IGKV2-30 IGKV2-28	1.39e-04	186	86	7	M27175
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	IGLV2-23 IGKV2D-30 IGKV2D-28 SIGLEC1 KLRD1 IGKV2-30 IGKV2-28	1.58e-04	190	86	7	M8240
Pathway	REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION	IGLV2-23 IGKV2D-30 IGKV2D-28 PLCG2 IGKV2-30 IGKV2-28	1.66e-04	134	86	6	M29840
Pathway	REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION	MALT1 IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 IGKV2-28	1.80e-04	136	86	6	M27207
Pathway	REACTOME_DIGESTION	SI ALPI ALPG	2.69e-04	21	86	3	MM15526
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	IGKV2D-28 PLCG2 IGHV4-4 IGKV2-28	3.01e-04	53	86	4	MM15716
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 IGKV2-28	3.27e-04	98	86	5	M27152
Pathway	REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS	IGLV2-23 IGKV2D-30 IGKV2D-28 PLCG2 IGKV2-30 IGKV2-28	3.53e-04	154	86	6	M39007
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGKV2D-28 PLCG2 IGHV4-4 IGKV2-28	4.26e-04	58	86	4	MM14914
Pathway	REACTOME_DIGESTION_AND_ABSORPTION	SI ALPI ALPG	4.58e-04	25	86	3	MM15557
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGKV2D-28 PLCG2 IGHV4-4 IGKV2-28	4.85e-04	60	86	4	MM14913
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	IGKV2D-28 PLCG2 IGHV4-4 IGKV2-28 PLD4	6.55e-04	114	86	5	MM14814
Pathway	WP_PRIMARY_OVARIAN_INSUFFICIENCY	TG TGFBR3 BMPR1A BMPR1B FSHR TRIM37	6.74e-04	174	86	6	M48058
Pathway	REACTOME_COMPLEMENT_CASCADE	IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 IGKV2-28	6.82e-04	115	86	5	M19752
Pathway	REACTOME_PARASITE_INFECTION	IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 IGKV2-28	7.09e-04	116	86	5	M29843
Pathway	REACTOME_SIGNALING_BY_BMP	TGFBR3 BMPR1A BMPR1B	8.71e-04	31	86	3	M1662
Pathway	REACTOME_SIGNALING_BY_BMP	TGFBR3 BMPR1A BMPR1B	8.71e-04	31	86	3	MM14789
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	MALT1 IGKV2D-28 PLCG2 IGHV4-4 IGKV2-28	1.22e-03	131	86	5	MM15717
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGKV2D-28 IGHV4-4 IGKV2-28	1.25e-03	35	86	3	MM17219
Pathway	KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY	BMPR1A BMPR1B	1.29e-03	9	86	2	M47844
Pathway	REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION	IGKV2D-28 IGHV4-4 IGKV2-28	1.71e-03	39	86	3	MM17212
Pathway	WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY	CYBB PIK3C2A PLCG2	1.84e-03	40	86	3	M39695
Pathway	KEGG_FOLATE_BIOSYNTHESIS	ALPI ALPG	1.95e-03	11	86	2	M2220
Pubmed	The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors.	TGFBR3 BMPR1A BMPR1B	3.71e-08	3	117	3	19726563
Pubmed	Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.	TSHR TG FCRL3	3.69e-07	5	117	3	19438904
Pubmed	Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor.	TGFBR3 BMPR1A BMPR1B	3.69e-07	5	117	3	18184661
Pubmed	Functional roles of Lgr4 and Lgr5 in embryonic gut, kidney and skin development in mice.	VIL1 SI ALPI ALPG	1.03e-06	23	117	4	24680895
Pubmed	The human immunoglobulin kappa locus. Characterization of the duplicated A regions.	IGKV2D-30 IGKV2-30 IGKV2-28	4.38e-06	10	117	3	1551402
Pubmed	Casein kinase 2 (CK2) phosphorylates the deubiquitylase OTUB1 at Ser16 to trigger its nuclear localization.	BMPR1A BMPR1B CSNK2A1	7.98e-06	12	117	3	25872870
Pubmed	Large-scale discovery of mouse transgenic integration sites reveals frequent structural variation and insertional mutagenesis.	MCPH1 EDIL3 CDH18	7.98e-06	12	117	3	30659012
Pubmed	Thyroid follicle development requires Smad1/5- and endothelial cell-dependent basement membrane assembly.	TG BMPR1A BMPR1B TIE1	1.01e-05	40	117	4	27068110
Pubmed	Studies of the interactions between the anticytokeratin 8 monoclonal antibody TS1, its antigen and its anti-idiotypic antibody alphaTS1.	IGKV2D-28 IGKV2-28	1.12e-05	2	117	2	12833571
Pubmed	Cyclic ADP ribose-dependent Ca2+ release by group I metabotropic glutamate receptors in acutely dissociated rat hippocampal neurons.	GRM1 GRM5	1.12e-05	2	117	2	22028929
Pubmed	Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP.	GRM1 GRM5	1.12e-05	2	117	2	9185557
Pubmed	Two V kappa germ-line genes related to the GAT idiotypic network (Ab1 and Ab3/Ab1') account for the major subfamilies of the mouse V kappa-1 variability subgroup.	IGKV2D-28 IGKV2-28	1.12e-05	2	117	2	3100621
Pubmed	Assignment of the BMPR1A and BMPR1B genes to human chromosome 10q22.3 and 4q23-->q24 byin situ hybridization and radiation hybrid map ping.	BMPR1A BMPR1B	1.12e-05	2	117	2	9730621
Pubmed	Structural and affinity studies of IgM polyreactive natural autoantibodies.	IGKV2D-28 IGKV2-28	1.12e-05	2	117	2	8993018
Pubmed	Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues.	BMPR1A BMPR1B	1.12e-05	2	117	2	10850425
Pubmed	Three-dimensional atomic structure of a catalytic subunit mutant of human protein kinase CK2.	CSNK2A1 CSNK2A3	1.12e-05	2	117	2	14646071
Pubmed	Differential molecular regulation of processing and membrane expression of Type-I BMP receptors: implications for signaling.	BMPR1A BMPR1B	1.12e-05	2	117	2	28357470
Pubmed	mGluR₁,5 activation improves network asynchrony and GABAergic synapse attenuation in the amygdala: implication for anxiety-like behavior in DBA/2 mice.	GRM1 GRM5	1.12e-05	2	117	2	22681774
Pubmed	Distinct roles of BMP receptors Type IA and IB in osteo-/chondrogenic differentiation in mesenchymal progenitors (C3H10T1/2).	BMPR1A BMPR1B	1.12e-05	2	117	2	15322331
Pubmed	mGluR1,5 activation protects cortical astrocytes and GABAergic neurons from ischemia-induced impairment.	GRM1 GRM5	1.12e-05	2	117	2	23280324
Pubmed	V genes of oxazolone antibodies in 10 strains of mice.	IGKV2D-28 IGKV2-28	1.12e-05	2	117	2	1936125
Pubmed	Metabotropic glutamate receptors in the main olfactory bulb drive granule cell-mediated inhibition.	GRM1 GRM5	1.12e-05	2	117	2	17093122
Pubmed	Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit.	CSNK2A1 CSNK2A3	1.12e-05	2	117	2	12860116
Pubmed	Influence of the hinge region and its adjacent domains on binding and signaling patterns of the thyrotropin and follitropin receptor.	TSHR FSHR	1.12e-05	2	117	2	25340405
Pubmed	BMPR1A is necessary for chondrogenesis and osteogenesis, whereas BMPR1B prevents hypertrophic differentiation.	BMPR1A BMPR1B	1.12e-05	2	117	2	32764110
Pubmed	[BMP7 signaling via BMPR1A, BMPR1B inhibits the proliferation of lung large carcinoma NCI-H460 cell].	BMPR1A BMPR1B	1.12e-05	2	117	2	20673479
Pubmed	Nucleotide sequences of the variable regions of a mouse monoclonal antibody MRK16.	IGKV2D-28 IGKV2-28	1.12e-05	2	117	2	2110659
Pubmed	In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis.	GRM1 GRM5	1.12e-05	2	117	2	31102766
Pubmed	The effect of ovarian reserve and receptor signalling on granulosa cell apoptosis during human follicle development.	BMPR1B FSHR	1.12e-05	2	117	2	29113831
Pubmed	Corticostriatal LTP requires combined mGluR1 and mGluR5 activation.	GRM1 GRM5	1.12e-05	2	117	2	12559117
Pubmed	Involvement of group I metabotropic glutamate receptors and glutamate transporters in the slow excitatory synaptic transmission in the spinal cord dorsal horn.	GRM1 GRM5	1.12e-05	2	117	2	18554818
Pubmed	Group 1 metabotropic glutamate receptors 1 and 5 form a protein complex in mouse hippocampus and cortex.	GRM1 GRM5	1.12e-05	2	117	2	27392515
Pubmed	Epithelial Bmpr1a regulates differentiation and proliferation in postnatal hair follicles and is essential for tooth development.	BMPR1A BMPR1B	1.12e-05	2	117	2	15102710
Pubmed	Genetic inactivation of mGlu5 receptor improves motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia.	GRM1 GRM5	1.12e-05	2	117	2	28982591
Pubmed	Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene.	TSHR TG	1.12e-05	2	117	2	14633662
Pubmed	Assignment of casein kinase 2 alpha sequences to two different human chromosomes.	CSNK2A1 CSNK2A3	1.12e-05	2	117	2	1577469
Pubmed	Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms.	IGKV2D-28 IGKV2-28	1.12e-05	2	117	2	2263605
Pubmed	IgM binding to injured tissue precedes complement activation during skeletal muscle ischemia-reperfusion.	IGKV2D-28 IGKV2-28	1.12e-05	2	117	2	15522311
Pubmed	Human fibrocytes coexpress thyroglobulin and thyrotropin receptor.	TSHR TG	1.12e-05	2	117	2	22517745
Pubmed	Selective induction of metabotropic glutamate receptor 1- and metabotropic glutamate receptor 5-dependent chemical long-term potentiation at oriens/alveus interneuron synapses of mouse hippocampus.	GRM1 GRM5	1.12e-05	2	117	2	18035501
Pubmed	Determination of group I metabotropic glutamate receptor subtypes involved in the frequency of epileptiform activity in vitro using mGluR1 and mGluR5 mutant mice.	GRM1 GRM5	1.12e-05	2	117	2	12623213
Pubmed	Group I metabotropic glutamate receptors mediate a dual role of glutamate in T cell activation.	GRM1 GRM5	1.12e-05	2	117	2	15184389
Pubmed	No evidence for a direct extracellular interaction between human Fc receptor-like 3 (MAIA) and the sperm ligand IZUMO1.	FCRL3 IZUMO1	1.12e-05	2	117	2	38381819
Pubmed	Early induced IgM as a predictor and risk factor for severe disease outcome after West Nile virus infection.	IGKV2D-28 IGKV2-28	1.12e-05	2	117	2	15219549
Pubmed	Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons.	GRM1 GRM5	1.12e-05	2	117	2	11591458
Pubmed	Amino acid sequence of the light chain variable region from a mouse anti-digoxin hybridoma antibody.	IGKV2D-28 IGKV2-28	1.12e-05	2	117	2	6404298
Pubmed	BMPR1A and BMPR1B Missense Mutations Cause Primary Ovarian Insufficiency.	BMPR1A BMPR1B	1.12e-05	2	117	2	31769494
Pubmed	Symmetric signal transduction and negative allosteric modulation of heterodimeric mGlu1/5 receptors.	GRM1 GRM5	1.12e-05	2	117	2	33279506
Pubmed	Molecular cloning of the human casein kinase II alpha subunit.	CSNK2A1 CSNK2A3	1.12e-05	2	117	2	2752008
Pubmed	Structure and sequence of an intronless gene for human casein kinase II-alpha subunit.	CSNK2A1 CSNK2A3	1.12e-05	2	117	2	8420794
Pubmed	mGluR5 Is Substitutable for mGluR1 in Cerebellar Purkinje Cells for Motor Coordination, Developmental Synapse Elimination, and Motor Learning.	GRM1 GRM5	1.12e-05	2	117	2	35805089
Pubmed	Decreased degradation of internalized follicle-stimulating hormone caused by mutation of aspartic acid 6.30(550) in a protein kinase-CK2 consensus sequence in the third intracellular loop of human follicle-stimulating hormone receptor.	CSNK2A1 FSHR	1.12e-05	2	117	2	21270425
Pubmed	Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression.	GRM1 GRM5	1.12e-05	2	117	2	31540330
Pubmed	Differential distribution of group I metabotropic glutamate receptors in developing human cortex.	GRM1 GRM5	1.12e-05	2	117	2	20149785
Pubmed	Opposing Fgf and Bmp activities regulate the specification of olfactory sensory and respiratory epithelial cell fates.	BMPR1A BMPR1B HES5	1.31e-05	14	117	3	20392740
Pubmed	Activation of pre-mRNA splicing by human RNPS1 is regulated by CK2 phosphorylation.	CSNK2A1 CSNK2A3	3.36e-05	3	117	2	15684395
Pubmed	Calcineurin inhibitor protein (CAIN) attenuates Group I metabotropic glutamate receptor endocytosis and signaling.	GRM1 GRM5	3.36e-05	3	117	2	19717561
Pubmed	TSH stimulation of human thyroglobulin and thyroid peroxidase gene transcription is partially dependent on internalization.	TSHR TG	3.36e-05	3	117	2	34896620
Pubmed	Isolation and characterization of human cDNA clones encoding the alpha and the alpha' subunits of casein kinase II.	CSNK2A1 CSNK2A3	3.36e-05	3	117	2	2174700
Pubmed	Age-Associated Increase in BMP Signaling Inhibits Hippocampal Neurogenesis.	BMPR1A BMPR1B	3.36e-05	3	117	2	25538007
Pubmed	Role of synaptic metabotropic glutamate receptors in epileptiform discharges in hippocampal slices.	GRM1 GRM5	3.36e-05	3	117	2	12364493
Pubmed	Dendrite complexity of sympathetic neurons is controlled during postnatal development by BMP signaling.	BMPR1A BMPR1B	3.36e-05	3	117	2	24048844
Pubmed	Distinct developmental programs require different levels of Bmp signaling during mouse retinal development.	BMPR1A BMPR1B	3.36e-05	3	117	2	15673568
Pubmed	Mapping of the human casein kinase II catalytic subunit genes: two loci carrying the homologous sequences for the alpha subunit.	CSNK2A1 CSNK2A3	3.36e-05	3	117	2	1766873
Pubmed	Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors.	TSHR FSHR	3.36e-05	3	117	2	11847099
Pubmed	Expression patterns of BMPRs in the developing mouse molar.	BMPR1A BMPR1B	3.36e-05	3	117	2	16432712
Pubmed	Analysis of the native murine bone morphogenetic protein serine threonine kinase type I receptor (ALK-3).	BMPR1A BMPR1B	3.36e-05	3	117	2	8707881
Pubmed	Iodinated TG in Thyroid Follicles Regulate TSH/TSHR Signaling for NIS Expression.	TSHR TG	3.36e-05	3	117	2	28396984
Pubmed	Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity.	TSHR FSHR	3.36e-05	3	117	2	15889138
Pubmed	The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways.	BMPR1A BMPR1B	3.36e-05	3	117	2	11714695
Pubmed	Transdifferentiation of alveolar epithelial type II to type I cells is controlled by opposing TGF-β and BMP signaling.	BMPR1A BMPR1B	3.36e-05	3	117	2	23831617
Pubmed	The type I BMP receptor ACVR1/ALK2 is required for chondrogenesis during development.	BMPR1A BMPR1B	3.36e-05	3	117	2	25413979
Pubmed	Granulosa cell-expressed BMPR1A and BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development.	BMPR1A BMPR1B	3.36e-05	3	117	2	20363875
Pubmed	Distinct regulatory functions of SLP-76 and MIST in NK cell cytotoxicity and IFN-gamma production.	PLCG2 CLNK	3.36e-05	3	117	2	18203684
Pubmed	Crystallization and preliminary characterization of crystals of human protein kinase CK2.	CSNK2A1 CSNK2A3	3.36e-05	3	117	2	11092945
Pubmed	Organic pyrophosphates as substrates for human alkaline phosphatases.	ALPI ALPG	3.36e-05	3	117	2	16742561
Pubmed	BMP signaling specifies the development of a large and fast CNS synapse.	BMPR1A BMPR1B	3.36e-05	3	117	2	23708139
Pubmed	Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis.	BMPR1A BMPR1B	3.36e-05	3	117	2	7750489
Pubmed	Sequencing of full-length cDNA encoding the alpha and beta subunits of human casein kinase II from human platelets and megakaryocytic cells. Expression of the casein kinase IIalpha intronless gene in a megakaryocytic cell line.	CSNK2A1 CSNK2A3	3.36e-05	3	117	2	12102635
Pubmed	BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injury.	BMPR1A BMPR1B	3.36e-05	3	117	2	20130193
Pubmed	Homology between TSH-R/Tg/TPO and Hashimoto's encephalopathy autoantigens.	TSHR TG	3.36e-05	3	117	2	31585887
Pubmed	Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer.	CSNK2A1 CSNK2A3	3.36e-05	3	117	2	20625391
Pubmed	Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours.	BMPR1A BMPR1B	3.36e-05	3	117	2	8605097
Pubmed	Two gene duplication events in the evolution of the human heat-stable alkaline phosphatases.	ALPI ALPG	3.36e-05	3	117	2	3443302
Pubmed	Role of type I receptors for anti-Müllerian hormone in the SMAT-1 Sertoli cell line.	BMPR1A BMPR1B	3.36e-05	3	117	2	15897891
Pubmed	Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans.	BMPR1A BMPR1B	3.36e-05	3	117	2	26584636
Pubmed	Structural predictions for the ligand-binding region of glycoprotein hormone receptors and the nature of hormone-receptor interactions.	TSHR FSHR	3.36e-05	3	117	2	8747461
Pubmed	SIRT1 Activation Attenuates Bone Cancer Pain by Inhibiting mGluR1/5.	GRM1 GRM5	3.36e-05	3	117	2	31270711
Pubmed	Expression of bone morphogenetic protein receptors in the developing mouse metanephros.	BMPR1A BMPR1B	3.36e-05	3	117	2	11701996
Pubmed	Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.	GRM1 GRM5	3.36e-05	3	117	2	20410124
Pubmed	The regulation of hippocampal LTP by the molecular switch, a form of metaplasticity, requires mGlu5 receptors.	GRM1 GRM5	3.36e-05	3	117	2	16024054
Pubmed	Role of lysophosphatidylcholine in brush-border intestinal alkaline phosphatase release and restoration.	ALPI ALPG	3.36e-05	3	117	2	19407215
Pubmed	Genomic structure and comparison of mouse tissue-specific alkaline phosphatase genes.	ALPI ALPG	3.36e-05	3	117	2	2286375
Pubmed	GLIPR1L1 is an IZUMO-binding protein required for optimal fertilization in the mouse.	IZUMO1 GLIPR1L1	3.36e-05	3	117	2	31672133
Pubmed	mGluR1 and mGluR5 Synergistically Control Cholinergic Synaptic Transmission in the Thalamic Reticular Nucleus.	GRM1 GRM5	3.36e-05	3	117	2	27466334
Pubmed	Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome.	GRM1 GRM5	3.36e-05	3	117	2	21571007
Pubmed	Intestinal Alkaline Phosphatase Regulates Tight Junction Protein Levels.	ALPI ALPG	3.36e-05	3	117	2	27106638
Pubmed	Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome.	GRM1 GRM5	3.36e-05	3	117	2	20534533
Pubmed	Effects of disruption of the embryonic alkaline phosphatase gene on preimplantation development of the mouse.	ALPI ALPG	3.36e-05	3	117	2	10767088
Pubmed	MUSEAP, a novel reporter gene for the study of long-term gene expression in immunocompetent mice.	ALPI ALPG	3.36e-05	3	117	2	11722850
Cytoband	6q24	GRM1 UTRN	1.79e-04	8	117	2	6q24
Cytoband	2p12	IGKV2D-30 IGKV2D-28 IGKV2-30 IGKV2-28	2.38e-04	117	117	4	2p12
Cytoband	Ensembl 112 genes in cytogenetic band chr2q37	UGT1A6 SH3BP4 ANO7 ALPI ALPG	2.96e-04	226	117	5	chr2q37
GeneFamily	Glycoprotein hormone receptors	TSHR FSHR	6.23e-05	3	83	2	199
GeneFamily	Alkaline phosphatases	ALPI ALPG	1.24e-04	4	83	2	1072
GeneFamily	Type 1 receptor serine/threonine kinases	BMPR1A BMPR1B	4.31e-04	7	83	2	345
GeneFamily	Glutamate metabotropic receptors\|Protein phosphatase 1 regulatory subunits	GRM1 GRM5	5.73e-04	8	83	2	281
GeneFamily	Immunoglobulin kappa locus at 2p11.2	IGKV2D-30 IGKV2D-28 IGKV2-30 IGKV2-28	5.76e-04	83	83	4	351
GeneFamily	Phospholipases	PLB1 PLCG2 PLD4	9.41e-04	42	83	3	467
GeneFamily	Tubulin tyrosine ligase family	TTLL8 TTLL6	1.83e-03	14	83	2	779
GeneFamily	Immunoglobulin like domain containing	NRCAM MALT1 FCRL3 TIE1 ADGRF5	1.95e-03	193	83	5	594
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#3	SOX3 SI IGLV2-23 IGKV2D-30 IGKV2D-28 IGHV4-4 IGKV2-30 IGKV2-28	6.00e-07	139	109	8	Arv_SC_fibroblast_500_K3
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#2	CH25H SI IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 ALPI IGKV2-28	2.00e-06	163	109	8	Arv_SC-hpx_blastocyst_500_K2
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#3	CH25H SI IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 ALPI IGKV2-28	3.39e-06	175	109	8	Arv_SC-H9hpx_500_K3
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2	SI IGLV2-23 IGKV2D-30 IGKV2D-28 IGHV4-4 IGKV2-30 IGKV2-28	3.95e-06	126	109	7	Arv_SC-HD_500_K2
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#5	SOX3 SI IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 ALPI IGKV2-28	4.73e-06	183	109	8	Arv_SC_fibroblast_1000_K5
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3	SI IGLV2-23 IGKV2D-30 IGKV2D-28 IGHV4-4 IGKV2-30 ALPI IGKV2-28	4.73e-06	183	109	8	Arv_SC-HD_1000_K3
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000	SOX3 VIL1 HECW1 CH25H SI CLDN7 ERVMER34-1 IGLV2-23 TTLL6 GLIPR1L1 IGKV2D-30 IGKV2D-28 IGKV2-30 ALPI IGKV2-28 SMTNL2 ALPG	1.11e-05	987	109	17	Arv_SC-H9hpx_1000
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000	SOX3 VIL1 HECW1 CH25H SI CLDN7 ERVMER34-1 IGLV2-23 TTLL6 GLIPR1L1 IGKV2D-30 IGKV2D-28 IGKV2-30 ALPI IGKV2-28 SMTNL2 ALPG	1.11e-05	987	109	17	Arv_SC-hpx_blastocyst_1000
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#4	CH25H SI IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 ALPI IGKV2-28	3.79e-05	244	109	8	Arv_SC-H9hpx_1000_K4
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_500	SOX3 VIL1 SI ERVMER34-1 IGLV2-23 TTLL6 IGKV2D-30 IGKV2D-28 IGHV4-4 IGKV2-30 IGKV2-28	4.35e-05	489	109	11	Arv_SC-HD_500
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500	SOX3 VIL1 SI ERVMER34-1 IGLV2-23 TTLL6 IGKV2D-30 IGKV2D-28 IGHV4-4 IGKV2-30 IGKV2-28	4.35e-05	489	109	11	Arv_SC_fibroblast_500
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000	SOX3 VIL1 SI ERVMER34-1 IGLV2-23 MALRD1 TTLL6 GLIPR1L1 IGKV2D-30 IGKV2D-28 IGHV4-4 IGKV2-30 ALPI IGKV2-28 SMTNL2	1.54e-04	986	109	15	Arv_SC_fibroblast_1000
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000	SOX3 VIL1 SI ERVMER34-1 IGLV2-23 MALRD1 TTLL6 GLIPR1L1 IGKV2D-30 IGKV2D-28 IGHV4-4 IGKV2-30 ALPI IGKV2-28 SMTNL2	1.54e-04	986	109	15	Arv_SC-HD_1000
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500	SOX3 CH25H SI IGLV2-23 GLIPR1L1 IGKV2D-30 IGKV2D-28 IGKV2-30 ALPI IGKV2-28	2.24e-04	492	109	10	Arv_SC-H9hpx_500
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500	SOX3 CH25H SI IGLV2-23 GLIPR1L1 IGKV2D-30 IGKV2D-28 IGKV2-30 ALPI IGKV2-28	2.24e-04	492	109	10	Arv_SC-hpx_blastocyst_500
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD7A NAALADL2 SH3BP4 JUP BMPR1B ADGRF5 SMS PLCG2 CLNK	1.85e-09	192	115	9	f7e7491426bbd6ed29a465b58bf67acb93dbb90a
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	AFF3 IGLV2-23 FCRL3 IGKV2D-30 IGKV2D-28 PLCG2 IGKV2-30 PLD4	2.41e-08	181	115	8	700adfb41e4e377530f0dd31be89e12f109f3469
ToppCell	IPF-Myeloid-DC_Langerhans\|IPF / Disease state, Lineage and Cell class	PALD1 NRCAM AFF3 SLC2A1 MALT1 GPR137B CLNK PLD4	2.85e-08	185	115	8	f8ee3cb2aa9ec70f9ce8797be2b155da27ef6464
ToppCell	IPF-Myeloid-DC_Langerhans\|Myeloid / Disease state, Lineage and Cell class	PALD1 NRCAM AFF3 SLC2A1 MALT1 GPR137B CLNK PLD4	2.85e-08	185	115	8	ced17f69486591c3cbbdc852a3e82c3f3a4a30d7
ToppCell	COPD-Myeloid-DC_Langerhans\|World / Disease state, Lineage and Cell class	PALD1 AFF3 SLC2A1 MALT1 GPR137B CLNK PLD4	2.00e-07	160	115	7	1b73a14ad6546d9f2812c19081278a79260abeae
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AFF3 TSHR IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 IGKV2-28	4.12e-07	178	115	7	107dae8b00c4257697a63700e72bb434cdb8406f
ToppCell	IPF-Myeloid-DC_Langerhans\|World / Disease state, Lineage and Cell class	PALD1 NRCAM AFF3 SLC2A1 GPR137B CLNK PLD4	4.79e-07	182	115	7	0e8cfbd8ea196f27a227dbb4d2eb93bc48d27922
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PCDHGB3 IGLV2-23 IGKV2D-30 IGKV2D-28 IGHV4-4 IGKV2-30 IGKV2-28	7.61e-07	195	115	7	df009b18898c10686f75cf72b4ec0eff18f5bb50
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	PALD1 CH25H CASP10 CLDN7 MELTF PLCG2 SLC12A7	9.02e-07	200	115	7	25f4c051c2e869481f33c22ad54de97efac444ad
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	PALD1 CH25H CASP10 CLDN7 MELTF PLCG2 SLC12A7	9.02e-07	200	115	7	da45a85a4667965b24ba824af871157af5b4cd19
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD7A NRCAM BMPR1B ADGRF5 PLCG2 CLNK	1.74e-06	140	115	6	e64f6aa57bc069cfe970089bd1c298433bfaf771
ToppCell	facs-Trachea-24m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB KCNH7 GRM5 MALT1 PLCG2 PLD4	2.80e-06	152	115	6	931c10245cde9b3290224cc1da46b2bf300b9ac2
ToppCell	COPD-Myeloid-DC_Langerhans\|COPD / Disease state, Lineage and Cell class	PALD1 AFF3 SLC2A1 GPR137B CLNK PLD4	3.50e-06	158	115	6	71af1319eec34bf7bc9361ec9ef720c280ce97d1
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	TSHR IGLV2-23 IGKV2D-30 IGHV4-4 IGKV2-30 IGKV2-28	4.65e-06	166	115	6	2b7b580bec8d9467b0deaf97098065f72dbf2a4f
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AFF3 IGLV2-23 FCRL3 IGKV2D-30 IGKV2D-28 IGKV2-30	5.15e-06	169	115	6	307571e57c3bfdf15f0fe1a8b36585e8e4f8a207
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLDN7 GRM1 ALMS1 FSHR SIGLEC1 CDH18	6.30e-06	175	115	6	65571d775d26a40e979dbf290a8e4320c0d9fb3f
ToppCell	COPD-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGLV2-23 IGKV2D-30 IGKV2D-28 PLCG2 IGKV2-30 IGKV2-28	6.30e-06	175	115	6	d73ee324479172501481b54967a0f3bd870fcf3a
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Immature_B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYBB AFF3 IGKV2D-28 PLCG2 IGKV2-30 IGKV2-28	6.94e-06	178	115	6	2e51c1596022b7047994ee13c18375bad19a54a5
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGLV2-23 IGKV2D-30 IGKV2D-28 IGHV4-4 IGKV2-30 IGKV2-28	7.16e-06	179	115	6	837ed81f18257f444eaeadc4fac89deedd4e3061
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGLV2-23 IGKV2D-30 IGKV2D-28 IGHV4-4 IGKV2-30 IGKV2-28	7.16e-06	179	115	6	b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSHR IGLV2-23 IGKV2D-30 PLCG2 IGKV2-30 IGKV2-28	7.40e-06	180	115	6	e3877f6ef5f54ff689058b4c996ab1851822f871
ToppCell	PCW_05-06-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PLEKHB1 TIE1 ADGRF5 PLCG2 PREX1 HES5	7.40e-06	180	115	6	5861b44acfb8fe92c281c8355bf19c059b3dcd64
ToppCell	COPD-Endothelial-VE_Capillary_A\|World / Disease state, Lineage and Cell class	PALD1 TSHZ2 AFF3 TGFBR3 TIE1 ADGRF5	7.63e-06	181	115	6	61608123959483ff60f07d8467996853c4371b6a
ToppCell	5'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CASP10 TIE1 ADGRF5 PREX1 HES5 ALPG	7.63e-06	181	115	6	7d7d1edeae4e0ebe40b324d1231cd26e27ba9d42
ToppCell	Immune_cells-Dendritic_cells\|Immune_cells / Lineage and Cell class	HPSE SH3BP4 GPR137B SMS KLRD1 PLD4	7.88e-06	182	115	6	99c7d4f1e7cd745643ba64b59190113bcd4e348e
ToppCell	cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGLV2-23 IGKV2D-30 IGKV2D-28 IGHV4-4 IGKV2-30 IGKV2-28	8.13e-06	183	115	6	5ab4aa0304b832f98fff89b6c24ad5b7dd014c11
ToppCell	Mild_COVID-19-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	AFF3 IGLV2-23 FCRL3 PLCG2 IGKV2-30 PLD4	8.13e-06	183	115	6	dea119e2988e954475f557f0bbe12556a83e81a4
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 NRCAM GRM1 CAPN8 MELTF GUCY2F	8.38e-06	184	115	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	droplet-Lung-21m-Epithelial-airway_epithelial-club_cell-club_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLB1 CRLF1 THSD7A TSHZ2 CLDN7 PLEKHB1	8.38e-06	184	115	6	204d16c48f822c98dc4118ac97a4f99f7e1163c8
ToppCell	COPD-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	PALD1 AFF3 SLC2A1 SH3BP4 GPR137B CLNK	8.38e-06	184	115	6	42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 NRCAM GRM1 CAPN8 MELTF GUCY2F	8.38e-06	184	115	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	droplet-Lung-21m-Epithelial-airway_epithelial-club_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLB1 CRLF1 THSD7A TSHZ2 CLDN7 PLEKHB1	8.38e-06	184	115	6	9365cdc52a2419e3f27e1c1c9310fa707d1e506b
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 NRCAM GRM1 CAPN8 MELTF GUCY2F	8.38e-06	184	115	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	AFF3 IGLV2-23 FCRL3 IGKV2D-28 PLCG2 PLD4	8.38e-06	184	115	6	3f8a359e40bebe58545f708682e5e5d1b70cf5cb
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	AFF3 IGLV2-23 FCRL3 IGKV2D-28 PLCG2 PLD4	8.38e-06	184	115	6	64bede8db709fd32f40c03265b96f0b12155bb8a
ToppCell	COPD-Endothelial-VE_Capillary_A\|COPD / Disease state, Lineage and Cell class	PALD1 TSHZ2 AFF3 TGFBR3 TIE1 ADGRF5	8.38e-06	184	115	6	5f4f7775d488ececf086c71441defecbee9d8a9c
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	AFF3 IGLV2-23 FCRL3 IGKV2D-28 PLCG2 PLD4	8.65e-06	185	115	6	609080adb2cfb105bb7b8efb617553833299f371
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSHR IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 IGKV2-28	8.65e-06	185	115	6	08bc817908076734d66f2805cb954141f2cc5a18
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSHR IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 IGKV2-28	8.65e-06	185	115	6	1704a12153a9b107bf03ecccd1a036cf61334d7a
ToppCell	IPF-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	PALD1 AFF3 SLC2A1 SH3BP4 GPR137B CLNK	8.92e-06	186	115	6	962c2dada19185628ead77c32fcb07fa95114247
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CLSTN3 THSD7A TIE1 ADGRF5 UTRN PREX1	9.19e-06	187	115	6	0ef82111b9049cc7ee78d64d240e1f10ab14d6b6
ToppCell	IPF-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	PALD1 AFF3 SLC2A1 SH3BP4 GPR137B CLNK	9.48e-06	188	115	6	47bb6caf84f70a1cda7d09803afdfd5182772e66
ToppCell	COPD-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	PALD1 AFF3 EDIL3 TGFBR3 ADGRF5 PREX1	9.48e-06	188	115	6	1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSHR IGLV2-23 IGKV2D-30 IGKV2D-28 IGKV2-30 IGKV2-28	9.48e-06	188	115	6	6844cebca177fdf38b21a40d606230a033717a3a
ToppCell	IPF-Myeloid-cDC1\|IPF / Disease state, Lineage and Cell class	PALD1 AFF3 SLC2A1 SH3BP4 GPR137B CLNK	9.48e-06	188	115	6	2331a2bae1383820d598e93aa86c75b101069bac
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD7A NRCAM BMPR1B ADGRF5 PLCG2 CLNK	9.77e-06	189	115	6	a9864873b19ab3e60acf11f288fa7275badc2e42
ToppCell	10x5'-blood-Lymphocytic_B-Memory_B_cells\|blood / Manually curated celltypes from each tissue	NRCAM AFF3 IGLV2-23 PLCG2 CLNK IGKV2-30	9.77e-06	189	115	6	8aa65ffc396ccc5e86a6d38b99a2d51c34c9b6d2
ToppCell	PCW_07-8.5-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CASP10 TIE1 ADGRF5 PLCG2 PREX1 HES5	1.01e-05	190	115	6	1307688255a1250fa300edf2c41f1affe31dcc98
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PALD1 AFF3 SH3BP4 TGFBR3 TIE1 ADGRF5	1.01e-05	190	115	6	0e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PALD1 AFF3 SH3BP4 TGFBR3 TIE1 ADGRF5	1.04e-05	191	115	6	f229abf69a1217194f74b0502486907e07dba989
ToppCell	COPD-Myeloid-cDC2\|World / Disease state, Lineage and Cell class	PALD1 AFF3 SH3BP4 MALT1 GPR137B PLD4	1.04e-05	191	115	6	4e4887175200a57e1b041f2f131e3df774df3509
ToppCell	COPD-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	PALD1 AFF3 SLC2A1 SH3BP4 GPR137B CLNK	1.04e-05	191	115	6	3480e6d27dd4291765bbbb2acdb6a2e4f02c8085
ToppCell	COPD-Myeloid-cDC1\|COPD / Disease state, Lineage and Cell class	PALD1 AFF3 SLC2A1 SH3BP4 GPR137B CLNK	1.07e-05	192	115	6	bd3d00b094d92463b06023361a71240851a542b8
ToppCell	Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|World / Lineage, Cell type, age group and donor	PALD1 AFF3 TGFBR3 TIE1 ADGRF5 PREX1	1.07e-05	192	115	6	1e156bab5ecf64627890d2de9b27603d9a01f28d
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THSD7A CASP10 TIE1 ADGRF5 PREX1 HES5	1.07e-05	192	115	6	5a0615fdc217554ccd611504b16e5d97628e207d
ToppCell	IPF-Myeloid-cDC2\|IPF / Disease state, Lineage and Cell class	PALD1 AFF3 SH3BP4 MALT1 GPR137B PLD4	1.07e-05	192	115	6	fe1de692fec48cba4a9bbc6eaa257260e8b4e800
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PALD1 AFF3 TGFBR3 TIE1 ADGRF5 PREX1	1.10e-05	193	115	6	f582e939e3e08a8a3f71deec78c33715be8faa51
ToppCell	droplet-Lung-3m-Endothelial-capillary_endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRICKLE1 EDIL3 JUP TIE1 ADGRF5 TRIM37	1.10e-05	193	115	6	1b6317b740cad2439f08b9e9895426d861e7a161
ToppCell	droplet-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRICKLE1 EDIL3 JUP TIE1 ADGRF5 TRIM37	1.10e-05	193	115	6	f5861cfa4401b476229a7c61cd64abad79a4bbfc
ToppCell	Control-NK_CD56bright\|Control / Disease condition and Cell class	AFF3 SH3BP4 TIE1 PLCG2 CLNK KLRD1	1.10e-05	193	115	6	8b1e7a226a6057e1097c1525984127b54e823876
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TSHR IGLV2-23 IGKV2D-30 IGKV2D-28 IGHV4-4 IGKV2-28	1.10e-05	193	115	6	34f6c13884fdf7f8a87f942fcb36a58cfac3f65d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD7A AFF3 TIE1 ADGRF5 PLCG2 UTRN	1.13e-05	194	115	6	a429d22c8c9d0fd3bfa9f877a6364cecad68db30
ToppCell	control-Lymphocytic-B_cells_1\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CYBB AFF3 JUP FCRL3 PLCG2 PLD4	1.17e-05	195	115	6	ff7956624b36df34e55295b295a71585accf07bd
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TSHR IGLV2-23 IGKV2D-30 IGKV2D-28 IGHV4-4 IGKV2-28	1.17e-05	195	115	6	13f4ee21568fd747608412d33559d10561dbb3c8
ToppCell	Biopsy_Other_PF-Immune-Plasma_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	TSHR IGLV2-23 IGKV2D-30 IGKV2D-28 IGHV4-4 IGKV2-30	1.17e-05	195	115	6	d0305c6a68c9e361507b04db94f86873085d49b3
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HECW1 NRCAM AFF3 GRM5 TMEM59L CDH18	1.20e-05	196	115	6	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	AFF3 FCRL3 PLCG2 CLNK IGKV2-30 PLD4	1.20e-05	196	115	6	e9fe5090452ffdde4bb81b62d57037d823281d00
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NRCAM CASP10 TSHR IGKV2D-30 PLCG2 IGKV2-30	1.20e-05	196	115	6	fd18a9ae8401121ae276adff1a85d5f938e2df91
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	AFF3 FCRL3 PLCG2 CLNK IGKV2-30 PLD4	1.20e-05	196	115	6	c2e17f3b2217f20bd7f28a1db4aa7d9a95c52a9c
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CLSTN3 THSD7A TIE1 ADGRF5 UTRN PREX1	1.20e-05	196	115	6	629236f95c838a473b5964a49b7c1b7ad863ea12
ToppCell	mild-Lymphocytic-B_cells_1\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CYBB AFF3 JUP FCRL3 PLCG2 PLD4	1.20e-05	196	115	6	1988088dd7e1ba947339fd1331beed482955e607
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	AFF3 FCRL3 IGKV2D-30 IGKV2D-28 IGKV2-28 PLD4	1.24e-05	197	115	6	76465bb2408c7c75f694e8f7cf1a606b796afc3a
ToppCell	Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CYBB PALD1 CLNK PREX1 MGAM2 PLD4	1.24e-05	197	115	6	7e15ed71881105dee5c7ffc052063ecc8ac0b36e
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	AFF3 IGKV2D-30 IGKV2D-28 IGHV4-4 IGKV2-28 PLD4	1.24e-05	197	115	6	9fe1b757f76c2d43d39aa9ac500eaba98723985c
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HECW1 NRCAM AFF3 GRM5 TMEM59L CDH18	1.27e-05	198	115	6	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 TIE1 PIK3C2A ADGRF5 UTRN PREX1	1.27e-05	198	115	6	451003a21162eeae90739fdb502bb50b362d80c8
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HECW1 NRCAM AFF3 GRM5 TMEM59L CDH18	1.27e-05	198	115	6	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	wk_08-11-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CRLF1 CLDN7 PLEKHB1 SLC2A1 TMEM59L UTRN	1.27e-05	198	115	6	84697f316d9195ebe838cf57f4dbdd9feea43bec
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AFF3 IGLV2-23 FCRL3 PLCG2 CLNK PREX1	1.27e-05	198	115	6	824461cf44098440ba8bc0df96735423ac65bda1
ToppCell	wk_08-11-Epithelial-Distal_epithelial_progenitor\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CRLF1 CLDN7 PLEKHB1 SLC2A1 TMEM59L UTRN	1.27e-05	198	115	6	eda85a592527992b51a00f288cff0c3239c47e6f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 TIE1 PIK3C2A ADGRF5 UTRN PREX1	1.27e-05	198	115	6	440af8f90c7afa1c07000806bcf9110b70f489fb
ToppCell	medial-2-Endothelial-Capillary_Aerocyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PALD1 TSHZ2 EDIL3 TGFBR3 TIE1 ADGRF5	1.31e-05	199	115	6	c5048b31649a0b7eddcd481b0458ed96508f5561
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PALD1 AFF3 EDIL3 TGFBR3 TIE1 ADGRF5	1.31e-05	199	115	6	7ed541309808f15d65a9c4b26be2050e077539e6
ToppCell	distal-Endothelial-Capillary_Aerocyte-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PALD1 TSHZ2 EDIL3 TGFBR3 TIE1 ADGRF5	1.31e-05	199	115	6	9021f4be004efd51bb3658e5bbff53589356b3df
ToppCell	medial-Endothelial-Capillary_Aerocyte\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PALD1 TSHZ2 EDIL3 TGFBR3 TIE1 ADGRF5	1.31e-05	199	115	6	84e30c39c2f050aa64af167999824c1cba32ba05
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	AFF3 IGKV2D-30 IGKV2D-28 IGHV4-4 IGKV2-28 PLD4	1.31e-05	199	115	6	8e02d3a066e79e0f2024a10738e0ea070513ef19
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_activated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CH25H TG GPR137B PREX1 MGAM2 PLD4	1.31e-05	199	115	6	82759af613ebfffe037afda55159bf6af812c3ac
ToppCell	medial-Endothelial-Capillary_Aerocyte-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PALD1 TSHZ2 EDIL3 TGFBR3 TIE1 ADGRF5	1.31e-05	199	115	6	f1039d1ab498fc58f0feba545df05833c235db74
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	PALD1 CH25H CASP10 LTBR PLCG2 SLC12A7	1.35e-05	200	115	6	0eccf41edefc3b8b5d0316f57d5ba572949aec2b
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal-BMP_responsible_cell\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	PALD1 CH25H CASP10 LTBR PLCG2 SLC12A7	1.35e-05	200	115	6	01d707c4f8ee0daac635b7260937b1baebc6fc23
ToppCell	medial-2-Endothelial-Capillary_Intermediate_1\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PALD1 TSHZ2 AFF3 TGFBR3 TIE1 ADGRF5	1.35e-05	200	115	6	a8adf5902540f6bb15b72efbb9c389b59d67e001
ToppCell	medial-Endothelial-Capillary_Intermediate_1\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PALD1 TSHZ2 AFF3 TGFBR3 TIE1 ADGRF5	1.35e-05	200	115	6	3ef7b7728615710c691aed8977e2582f19692cf9
ToppCell	distal-2-Endothelial-Capillary_Intermediate_1\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PALD1 TSHZ2 EDIL3 TGFBR3 TIE1 ADGRF5	1.35e-05	200	115	6	7a99f28670ffb8ece7873d8a9bcd2a3936d0255d
ToppCell	distal-Endothelial-Capillary_Intermediate_1-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PALD1 TSHZ2 EDIL3 TGFBR3 TIE1 ADGRF5	1.35e-05	200	115	6	43bc48413b100a06f8edd9acd812296788fcbf5b
ToppCell	mild-NK_CD56bright\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CLSTN3 SH3BP4 TIE1 CLNK UTRN KLRD1	1.35e-05	200	115	6	a195bc6784346f706d4cd5b740adac1d950ce88a
ToppCell	distal-Endothelial-Capillary_Aerocyte\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PALD1 TSHZ2 EDIL3 TGFBR3 TIE1 ADGRF5	1.35e-05	200	115	6	b91f8eb67752a77e1e08e462e50f1b5923695e1b
ToppCell	distal-1-Endothelial-Capillary_Aerocyte\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PALD1 EDIL3 ERVMER34-1 TGFBR3 TIE1 ADGRF5	1.35e-05	200	115	6	59bacd738433cec6d05624a25fdfc087fb3ca3b5
ToppCell	distal-Endothelial-Capillary_Intermediate_1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PALD1 TSHZ2 EDIL3 TGFBR3 TIE1 ADGRF5	1.35e-05	200	115	6	4d6714d48738cdee7d535923f6dd2431e5304741
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PALD1 AFF3 EDIL3 TGFBR3 TIE1 PREX1	1.35e-05	200	115	6	105c67e4f5eff036013d655c8e8ac577d32dae2e
ToppCell	medial-Endothelial-Capillary_Intermediate_1-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PALD1 TSHZ2 AFF3 TGFBR3 TIE1 ADGRF5	1.35e-05	200	115	6	707148e01e961097819a05437a842b7d3bf72b0a
Drug	Aspartylglutamate	TSHR GRM1 GRM5 SLC2A1 BRAP TBCCD1 FSHR	5.57e-10	40	104	7	CID000151403
Drug	corticosterone hemisuccinate	GRM1 GRM5 TRIM37	9.20e-07	5	104	3	CID000159273
Drug	THV	CRLF1 TSHR TG TRIM37	1.88e-06	20	104	4	CID011840983
Drug	Delcorine; Up 200; 8.4uM; MCF7; HT_HG-U133A	HECW1 MCPH1 OGFR CASP10 GRM1 EDIL3 MELTF AOC3	3.20e-06	195	104	8	3613_UP
Drug	phenylarsine oxide	GRM1 GRM5 SLC2A1 TBCCD1 FSHR LTBR PLCG2 KLRD1 PLD4	4.85e-06	275	104	9	CID000004778
Drug	AC1NRAS8	APEH TG AOC3 CLNK	1.34e-05	32	104	4	CID005288068
Drug	Wy-16,225	OGFR GRM1 GRM5	1.49e-05	11	104	3	CID000040841
Drug	Seldomycin-5	APEH HPSE	2.07e-05	2	104	2	CID003043877
Drug	xanthanoic acid	GRM1 GRM5	2.07e-05	2	104	2	CID000065736
Drug	phosphorus anion	APEH BRAP SMS TRIM37	2.69e-05	38	104	4	CID009548888
Drug	beta-glycerophosphate	HPSE BRAP SIGLEC1 ALPI	3.31e-05	40	104	4	CID000002526
Drug	Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; PC3; HT_HG-U133A	PAPPA2 TSHZ2 AFF3 CASP10 TSHR TG KLRD1	3.64e-05	199	104	7	3759_UP
Drug	phenobarbital	GABRD UGT1A6 CH25H GRM1 GRM5 SLC2A1 AOC3 TRIM37 ALPI	4.10e-05	360	104	9	CID000004763
Drug	allantoate	APEH BRAP AOC3 SIGLEC1	4.85e-05	44	104	4	CID000000203
Drug	pheophytin	UGT1A6 HPSE ALMS1 PIK3C2A SIGLEC1 TRIM37 ALPI ALPG	4.86e-05	284	104	8	CID000000250
Drug	ethylglutamate	APEH GRM1 GRM5	4.97e-05	16	104	3	CID000014241
Drug	stannite	SIGLEC1 TRIM37	6.18e-05	3	104	2	CID006367227
Drug	fenobam	GRM1 GRM5	6.18e-05	3	104	2	CID000162834
Disease	Autoimmune thyroiditis	TSHR TG FCRL3	1.80e-07	4	106	3	C0920350
Disease	cardiomyopathy (is_implicated_in)	TSHR POMT1 JUP	4.19e-05	19	106	3	DOID:0050700 (is_implicated_in)
Disease	antiphospholipid syndrome	TSHR SH3BP4 CDH18	8.63e-05	24	106	3	EFO_0002689
Disease	1,5 anhydroglucitol measurement	PCDHA10 SI MGAM2	1.54e-04	29	106	3	EFO_0008009
Disease	Idiopathic generalized epilepsy	GABRD SLC2A1	1.90e-04	6	106	2	C0270850
Disease	Graves disease	PRICKLE1 TSHR TG FCRL3	2.12e-04	81	106	4	EFO_0004237
Disease	rheumatoid arthritis	AFF3 GRM5 MELTF FCRL3 CLNK PREX1 SMTNL2 PLD4	2.69e-04	462	106	8	EFO_0000685
Disease	rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement	AFF3 FCRL3 CLNK SMTNL2 PLD4	3.79e-04	170	106	5	EFO_0000685, EFO_0007791, EFO_0007837
Disease	autoimmune disease	KCNH7 AFF3 TSHR TG CLNK	4.11e-04	173	106	5	EFO_0005140
Disease	Graves Disease	TSHR FCRL3	4.53e-04	9	106	2	C0018213
Disease	mean corpuscular hemoglobin concentration	VIL1 CRISP2 CASP10 TSHR PLEKHB1 SLC2A1 BRAP ADGRF5 LTBR SLC12A7 PREX1 SMIM19	6.20e-04	1105	106	12	EFO_0004528
Disease	juvenile polyposis syndrome (implicated_via_orthology)	BMPR1A BMPR1B	9.72e-04	13	106	2	DOID:0050787 (implicated_via_orthology)
Disease	Congenital Hypothyroidism	TSHR TG	9.72e-04	13	106	2	C0010308
Disease	tyrosine-protein kinase receptor Tie-1, soluble measurement	ADAMTS13 TIE1	9.72e-04	13	106	2	EFO_0008312
Disease	congenital hypothyroidism (implicated_via_orthology)	TSHR TG	1.13e-03	14	106	2	DOID:0050328 (implicated_via_orthology)
Disease	narcolepsy-cataplexy syndrome	PALD1 EDIL3 PREX1	1.27e-03	59	106	3	MONDO_0016158
Disease	gestational age	NAALADL2 TGFBR3 MALRD1 UTRN	1.57e-03	138	106	4	EFO_0005112
Disease	Eye Abnormalities	BMPR1A BMPR1B	1.68e-03	17	106	2	C0015393
Disease	non-Hodgkin lymphoma (is_implicated_in)	CASP10 MALT1	1.68e-03	17	106	2	DOID:0060060 (is_implicated_in)
Disease	urate measurement, bone density	PLB1 TSHZ2 UGT1A6 NAALADL2 TG BMPR1A CSNK2A1 UTRN	1.79e-03	619	106	8	EFO_0003923, EFO_0004531
Disease	cognitive function measurement, self reported educational attainment	KCNH7 AFF3 ALMS1 CLNK PREX1 TRIM37	1.81e-03	355	106	6	EFO_0004784, EFO_0008354
Disease	bipolar disorder, body mass index	TRIM42 TSHZ2 NAALADL2	2.24e-03	72	106	3	EFO_0004340, MONDO_0004985
Disease	Joubert syndrome 1	TRIM37 TCTN2	2.57e-03	21	106	2	C4551568
Disease	Attention Deficit Disorder	GRM1 GRM5	2.82e-03	22	106	2	C0041671
Disease	Minimal Brain Dysfunction	GRM1 GRM5	2.82e-03	22	106	2	C1321905
Disease	epilepsy (implicated_via_orthology)	KCNH7 NRCAM PRICKLE1 SLC12A7	2.88e-03	163	106	4	DOID:1826 (implicated_via_orthology)
Disease	Epilepsy, Benign Psychomotor, Childhood	GRM1 GRM5	3.08e-03	23	106	2	C0393672
Disease	Epilepsy, Lateral Temporal	GRM1 GRM5	3.08e-03	23	106	2	C0393682
Disease	Uncinate Epilepsy	GRM1 GRM5	3.08e-03	23	106	2	C0014558
Disease	Epilepsy, Temporal Lobe	GRM1 GRM5	3.08e-03	23	106	2	C0014556
Disease	Attention deficit hyperactivity disorder	GRM1 GRM5	3.35e-03	24	106	2	C1263846
Disease	short-term memory	DNAH12 GPR137B CDH18	3.36e-03	83	106	3	EFO_0004335
Disease	carotid plaque build	EPG5 TGFBR3 BMPR1B	3.48e-03	84	106	3	EFO_0006501

Protein segments in the cluster

Peptide	Gene	Start	Entry
GFVSSTWTYYLQTDN	TMEM59L	166	Q9UK28
HVSITNSILHSYDYW	AFF3	1161	P51826
TSNVFLQWAHSYADG	ERVPABLB-1	61	P60509
LGYVSDHWAQYVSHN	EPG5	651	Q9HCE0
TNHRVWDYAGDNYVH	BRAP	361	Q7Z569
WDYAGDNYVHRLVAS	BRAP	366	Q7Z569
ANWTAGLSVHYSQDS	CLSTN3	326	Q9BQT9
GLSVHYSQDSSLIYW	CLSTN3	331	Q9BQT9
DHFDAARSYGQYWTQ	ALMS1	386	Q8TCU4
ENHAPWSISDYFYQT	AGGF1	96	Q8N302
LEIYWETDYNHSGTI	CAPN8	611	A6NHC0
LLNVYTQWAESGYSS	DHX16	881	O60231
SWTQLYLITDYHENG	BMPR1B	271	O00238
NAVVGHYTQLVWYST	CRISP2	131	P16562
FHGQQVLYWESESSQ	ADAMTS13	1371	Q76LX8
STLLNYDYVWDTVFH	AOC3	466	Q16853
SWAYIQYESLDAAHA	RBM15	491	Q96T37
WNSTLQTLVASYEAY	PTPN23	651	Q9H3S7
NTYHVYHNTEDLWGE	PALD1	221	Q9ULE6
AFRDDDGHYSQTYWN	ANO7	831	Q6IWH7
AYAAWTTELGNLQSH	RELCH	706	Q9P260
SQSLVYSDGNTYLNW	IGKV2D-30	46	A0A075B6S6
WTYVSAVHTEGNYGE	GRM5	211	P41594
AYVEVWSSNGTENYS	MCPH1	11	Q8NEM0
EHYNVHNLYGWSQTR	MGAM2	1431	Q2M2H8
GTYWCHVYNDRDSQD	MALT1	286	Q9UDY8
AAAETYANISWEYEG	NRCAM	1076	Q92823
YANISWEYEGPEHVN	NRCAM	1081	Q92823
EEFYNQTWVHRYGES	SLC2A1	41	P11166
WDVSGQSSNDKYYTH	HIPK1	31	Q86Z02
EWIGEIYHSGSTNYN	IGHV4-4	66	A0A075B6R2
EEYFQHAWTYTNGID	KCNH7	701	Q9NS40
SYYSIGHSQDLVIHW	HECW1	86	Q76N89
WYPQAEVQNHSTSSY	ERVMER34-1	81	Q9H9K5
SQSLLHSNGYNYLDW	IGKV2D-28	46	P01615
SDVGSYNLVSWYQQH	IGLV2-23	46	P01705
FAAHGISSNWVSNYE	PIK3C2A	691	O00443
AQSTYADGIQDYWAD	FAM205A	186	Q6ZU69
VGLDYSNPWHSSYVQ	DNAH12	181	Q6ZR08
DIVYYWSESQEHIHG	GABRD	191	O14764
YWISSSHNTYLTGDQ	PLCG2	321	P16885
ADSGYNAWLSYHIVQ	PCDHGB3	596	Q9Y5G1
AVIWRGESHQYNADY	IGHV8-51-1	66	P0DTE2
GLEVESLQYYASQHW	NUDT13	251	Q86X67
WQQTYTYDSGIHSGA	JUP	16	P14923
DSVTWHHYYLNGRTA	HPSE	291	Q9Y251
AAWEVGSGQLHYSVY	PCDHA10	21	Q9Y5I2
GYNAWLSYELQSAAV	PCDHA10	601	Q9Y5I2
AGTYAHTVNRNWYSD	ALPI	176	P09923
LDTAQESVHVASYYW	PLD4	126	Q96BZ4
GYHGSTVWNVEEHRY	POMT1	501	Q9Y6A1
AGAYAHTVNRNWYSD	ALPG	176	P10696
ASGYNHDETQWYEDS	PRICKLE1	506	Q96MT3
VDHTQNTTDGWYLYA	MALRD1	1136	Q5VYJ5
GYLDQWATRAYSSHE	PAPPA2	1186	Q9BXP8
SQVALYTFGHRANEW	DCP1B	36	Q8IZD4
AYSNDGEHWTVYQDE	EDIL3	411	O43854
YESHVVEWGNQDDYQ	CSNK2A3	26	Q8NEV1
ATYENSNIAIYEGDW	GUCY2F	556	P51841
SWTQLYLITDYHENG	BMPR1A	301	P36894
YESHVVEWGNQDDYQ	CSNK2A1	26	P68400
SISHSLAQGDTYWYH	FCRL3	46	Q96P31
ATTQSDQDYHYLGDW	CDH18	756	Q13634
YNIYLTGWDESQANH	CYBB	476	P04839
RHAITAWYNETQFYD	GLIPR1L1	111	Q6UWM5
SQSLLHSNGYNYLDW	IGKV2-28	46	A0A075B6P5
SQSLVYSDGNTYLNW	IGKV2-30	46	P06310
YVSFRHVEEGSWYIQ	CASP10	446	Q92851
WHQASEGLTDYSFYR	IZUMO1	186	Q8IYV9
RSYHVYPEQGNWEAS	DHRS7C	226	A6NNS2
KSQYHNYAIDWQTGA	FSHR	426	P23945
RYNWTYVSAVHTEGN	GRM1	221	Q13255
RWYGQDNTCEEYHTV	CRLF1	176	O75462
ASGVFLENLWSTYAH	SLC12A7	371	Q9Y666
TTYHWQELSYTEGLS	METTL17	141	Q9H7H0
VNIWLSVEDHSGYNF	CH25H	206	O95992
TALHWSAYYNNPEHV	INVS	151	Q9Y283
NWTDNYDLLEDNHSY	OGFR	116	Q9NZT2
QGDSMEGSYEHWYQQ	IGLV3-32	41	A0A0A0MS00
VHSFDYDWYNVSDQA	GPR137B	266	O60478
IFDGNVAHISTWLYQ	UTRN	1656	P46939
TWQDHGYLATYTNKN	SMS	41	P52788
YTHVNGWANGAYSLV	SOX3	261	P41225
HWYITQLEAAQTSYI	TRIM37	416	O94972
LYTYWSAGADSQSVQ	TRIM42	571	Q8IWZ5
ATQTYEAWLGHEYLH	MELTF	336	P08582
YDFLLTWSHQIGDSY	SH3BP4	896	Q9P0V3
HYDYNVTDWSTCQLS	THSD7A	1221	Q9UPZ6
ADYHSNGYTVTNGWK	PREX1	346	Q8TCU6
YATYERGNTQHVWIN	SI	441	P14410
GISSFSYWHQYTQRE	PLB1	1301	Q6P1J6
SYWHQYTQREDFAVV	PLB1	1306	Q6P1J6
QDYSEGYSWCLQEAV	HES5	86	Q5TA89
EEYWSRYVLHIQGSQ	SLC6A7	191	Q99884
TTQYGGQYRTVHTEW	APEH	36	P13798
VSNYDEVYWNTSAGI	ADGRF5	496	Q8IZF2
ACSWYGHQIVTDFYN	CLDN7	136	O95471
HNEWYIGEYSRQAVE	CLNK	306	Q7Z7G1
SGHTSVYWYQQALGL	TRBV5-8	46	A0A5A2
SSLSYDIHYWIGQDS	VIL1	56	P09327
SVVDYNAYAGVWSQD	YTHDF3	481	Q7Z739
WEDLTQQYYSLVHGD	TTLL8	301	A6PVC2
NQLYFTYSVHWEESD	TM9SF4	246	Q92544
WLDGTLGYYHDETAQ	PLEKHB1	46	Q9UF11
NGSYFYTLDWHEAQD	TIE1	161	P35590
YTVHEAWNEATNVYL	SMIM19	16	Q96E16
LGYQHVDLQNFSSSW	SMTNL2	366	Q2TAL5
SSHATLYWYQQALGQ	TRBV7-7	46	A0A0K0K1E9
TTHPAQLTYTWYQDG	SIGLEC1	1111	Q9BZZ2
HSTISGTDYIHWYRQ	TRAV26-2	41	A0A0B4J265
SAYLEDHSYNVEQIW	TTLL6	291	Q8N841
TAVYANILSDSYWSG	TSHZ2	126	Q9NRE2
ATCAENSYNEHWNYL	LTBR	81	P36941
TSESWTNQDDIFYAY	nan	26	Q6ZS52
WNDYSHQAFVYDHLS	TBCCD1	166	Q9NVR7
KDIDEQTQEHWYTSY	WDR24	666	Q96S15
QTQEHWYTSYIDLLQ	WDR24	671	Q96S15
AAHDLTWYQYHSLDV	UGT1A6	476	P19224
VEAAATWYYSLEHST	TG	2556	P01266
WTQYYQGELHSQCVA	TCTN2	656	Q96GX1
WYIYSHTGETAGRQQ	TGFBR3	806	Q03167
YTHSEYYNHAIDWQT	TSHR	476	P16473
GNHEYYTSDVSNWFA	TMPPE	276	Q6ZT21
SQQFYWIGLSYSEEH	KLRD1	111	Q13241
HSYNGQEWASSTAII	NAALADL2	456	Q58DX5